You have 8 free searches left this month | for more free features.

Histiocytoma, Benign Fibrous

Showing 1 - 25 of 2,345

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

Enrolling by invitation
  • Ewing Sarcoma
  • +8 more
  • Santa Monica, California
    Sarcoma Oncology Center
Feb 23, 2022

Dermatofibroma of Skin Trial in Salt Lake City (1540 nanometer Erbium glass laser)

Completed
  • Dermatofibroma of Skin
  • 1540 nanometer Erbium glass laser
  • Salt Lake City, Utah
    University of Utah Dermatology
Jun 1, 2021

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

Recruiting
  • Ewing Sarcoma
  • +10 more
  • Los Angeles, California
  • +16 more
Jan 18, 2022

Angiomatoid Fibrous Histiocytoma:Single Institution Case-series

Completed
  • Angiomatoid Fibrous Histiocytoma
    • Bologna, Italy
      IRCC Rizzoli Orthopedic Institute
    Feb 11, 2020

    Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

    Not yet recruiting
    • Undifferentiated Pleomorphic Sarcoma
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Nov 1, 2023

    Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

    Recruiting
    • Soft Tissue Sarcoma Adult
    • +6 more
    • Bordeaux, France
      Institut Bergonie
    Feb 1, 2022

    Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

    Active, not recruiting
    • Sarcoma
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 26, 2022

    Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound

    Recruiting
    • Undifferentiated Pleomorphic Sarcoma
    • ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
    • San Francisco, California
      University of California, San Francisco
    Feb 28, 2022

    Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent

    Recruiting
    • Locally Advanced Undifferentiated Pleomorphic Sarcoma
    • +3 more
    • Sintilimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

    Not yet recruiting
    • Osteosarcoma
    • +25 more
      • (no location specified)
      Aug 24, 2022

      Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone Trial in United States (biological, drug, procedure, radiation)

      Completed
      • Osteosarcoma
      • Malignant Fibrous Histiocytoma (MFH) of Bone
      • Bevacizumab
      • +7 more
      • San Diego, California
      • +4 more
      Jun 21, 2019

      Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

      Recruiting
      • Metastatic Leiomyosarcoma
      • +17 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 13, 2022

      Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

      Not yet recruiting
      • Metastatic Extraskeletal Myxoid Chondrosarcoma
      • +3 more
      • Biopsy
      • +6 more
      • (no location specified)
      Apr 25, 2023

      Sarcoma, Soft Tissue Trial in Beijing (Recombinant anti-PD-1 humanized mAb injection)

      Not yet recruiting
      • Sarcoma, Soft Tissue
      • Recombinant anti-PD-1 humanized monoclonal antibody injection
      • Beijing, Beijing, China
        Beijing Jishuitan Hospital
      Dec 31, 2021

      Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

      Recruiting
      • Sarcoma
      • +3 more
      • Isolated Limb Infusion
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Nov 21, 2022

      Sarcoma Trial in London (Pembrolizumab, Gemcitabine)

      Active, not recruiting
      • Sarcoma
      • London, United Kingdom
        Royal Marsden
      Jun 29, 2021

      Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in

      Active, not recruiting
      • Dedifferentiated Liposarcoma
      • +5 more
      • Ipilimumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 25, 2022

      Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

      Withdrawn
      • Soft Tissue Sarcoma
      • +12 more
      • Providence, Rhode Island
      • +1 more
      Nov 30, 2021

      Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

      Completed
      • Adult Alveolar Soft Part Sarcoma
      • +18 more
      • Portland, Oregon
      • +1 more
      Sep 23, 2021

      Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

      Recruiting
      • Bone Sarcoma
      • +6 more
      • Treatment by Regorafenib
      • Treatment by Placebo
      • Besançon, France
      • +15 more
      Aug 18, 2022

      Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

      Active, not recruiting
      • Advanced Soft Tissue Sarcoma
      • +26 more
      • Doxorubicin Hydrochloride
      • +3 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jan 6, 2023

      Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

      Withdrawn
      • Sarcoma
      • +12 more
      • Providence, Rhode Island
      • +1 more
      Jul 26, 2021